메뉴 건너뛰기




Volumn 16, Issue 10, 2002, Pages 2169-2170

P-glycoprotein as a therapeutic target: Good news [7]

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GLUCOSYLCERAMIDE; GLYCOPROTEIN P; VALSPODAR; VINCRISTINE;

EID: 0036798452     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402664     Document Type: Letter
Times cited : (4)

References (8)
  • 1
    • 0036939821 scopus 로고    scopus 로고
    • The cyclosporin PSC 833 increases survivald and delays engraftment of human multidrug resistant leukemia cells in xenotransplanted NOD-SCID mice
    • (in press)
    • Lehne G, Sørensen DR, Tjønnfjord GE, Beiske C, Hagve T-A, Rugstad HE, Clausen SOPE. The cyclosporin PSC 833 increases survivald and delays engraftment of human multidrug resistant leukemia cells in xenotransplanted NOD-SCID mice. Leukemia 2002; 16: (in press).
    • (2002) Leukemia , vol.16
    • Lehne, G.1    Sørensen, D.R.2    Tjønnfjord, G.E.3    Beiske, C.4    Hagve, T.-A.5    Rugstad, H.E.6    Clausen, S.O.P.E.7
  • 2
    • 0007544439 scopus 로고    scopus 로고
    • MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine
    • van Helvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkel A, Borst P, van Meer G. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 1996; 87: 507-517.
    • (1996) Cell , vol.87 , pp. 507-517
    • van Helvoort, A.1    Smith, A.J.2    Sprong, H.3    Fritzsche, I.4    Schinkel, A.5    Borst, P.6    van Meer, G.7
  • 4
    • 0035883083 scopus 로고    scopus 로고
    • Signaling pathways activated by daunorubicin
    • Laurent G, Jaffrézou J-P. Signaling pathways activated by daunorubicin. Blood 2001; 98: 913-924
    • (2001) Blood , vol.98 , pp. 913-924
    • Laurent, G.1    Jaffrézou, J.-P.2
  • 5
    • 0035819885 scopus 로고    scopus 로고
    • Targeting ceramide metabolism - A strategy for overcoming drug resistance
    • Senchenkov A, Litvak DA, Cabot MC. Targeting ceramide metabolism - a strategy for overcoming drug resistance. J Natl Cancer Inst 2001; 93: 347-357.
    • (2001) J. Natl. Cancer Inst , vol.93 , pp. 347-357
    • Senchenkov, A.1    Litvak, D.A.2    Cabot, M.C.3
  • 6
    • 0032836990 scopus 로고    scopus 로고
    • Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase
    • Nicholson KM, Quinn DM, Kellet GL, Warr JR. Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase. Br J Cancer 1999; 81: 423-430.
    • (1999) Br. J. Cancer , vol.81 , pp. 423-430
    • Nicholson, K.M.1    Quinn, D.M.2    Kellet, G.L.3    Warr, J.R.4
  • 7
    • 0035031007 scopus 로고    scopus 로고
    • Signal transduction pathways and transcriptional mechanisms as targets for prevention of emergence of multidrug resistance in human cancer cells
    • Shtil AA. Signal transduction pathways and transcriptional mechanisms as targets for prevention of emergence of multidrug resistance in human cancer cells. Curr Drug Targets 2001; 2: 57-77.
    • (2001) Curr. Drug Targets , vol.2 , pp. 57-77
    • Shtil, A.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.